Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 340

    1.

    Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.

    Radha V, Vimaleswaran KS, Babu HN, Abate N, Chandalia M, Satija P, Grundy SM, Ghosh S, Majumder PP, Deepa R, Rao SM, Mohan V.

    Diabetes Care. 2006 May;29(5):1046-51.PMID: 16644635 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects.

    Li LL, Ma XL, Ran JX, Sun XF, Xu LM, Ren J, Mao XM.

    Clin Exp Pharmacol Physiol. 2008 Feb;35(2):187-91. Epub 2007 Oct 17.PMID: 17941898 [PubMed - indexed for MEDLINE]Related articles

    3.

    A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.

    Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K.

    Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):465-9.PMID: 15739197 [PubMed - indexed for MEDLINE]Related articles

    4.

    A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

    Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP.

    Eur J Endocrinol. 2001 Mar;144(3):277-82.PMID: 11248748 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.

    Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.

    Diabetologia. 2001 Sep;44(9):1170-6.PMID: 11596673 [PubMed - indexed for MEDLINE]Related articles

    7.

    Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.

    Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clément K, Charles MA, Tauber M, Weill J, Froguel P.

    BMC Med Genet. 2005 Mar 22;6:11.PMID: 15784141 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes.

    Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, Radha V, Deepa R, Mohan V.

    Diabetes. 2005 Apr;54(4):1207-13.PMID: 15793263 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population.

    Li L, Cheng LX, Nsenga R, He MA, Wu TC.

    Clin Cardiol. 2006 Jul;29(7):300-4.PMID: 16881538 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.

    Meshkani R, Taghikhani M, Larijani B, Bahrami Y, Khatami S, Khoshbin E, Ghaemi A, Sadeghi S, Mirkhani F, Molapour A, Adeli K.

    Clin Chem Lab Med. 2007;45(4):477-82.PMID: 17439324 [PubMed - indexed for MEDLINE]Related articles

    11.

    Lack of association between serum adiponectin levels and the Pro12Ala polymorphism in Asian Indians.

    Radha V, Vimaleswaran KS, Babu S, Deepa R, Anjana M, Ghosh S, Majumder PP, Rao MR, Mohan V.

    Diabet Med. 2007 Apr;24(4):398-402. Epub 2007 Feb 28.PMID: 17335469 [PubMed - indexed for MEDLINE]Related articles

    12.

    Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.

    Lee BC, Lee HJ, Chung JH.

    Neurosci Lett. 2006 Dec 20;410(2):141-5. Epub 2006 Nov 3.PMID: 17084528 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.

    Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Yetkin I, Ayvaz G, Cakir N, Arslan M.

    Gynecol Endocrinol. 2005 Oct;21(4):206-10.PMID: 16316841 [PubMed - indexed for MEDLINE]Related articles

    14.

    No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects.

    Rhee EJ, Kwon CH, Lee WY, Kim SY, Jung CH, Kim BJ, Sung KC, Kim BS, Oh KW, Kang JH, Park SW, Kim SW, Lee MH, Park JR.

    Circ J. 2007 Mar;71(3):338-42.PMID: 17322631 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Lack of association between the Pro12Ala polymorphism of the PPAR-gamma 2 gene and type 2 diabetes mellitus in the Qatari consanguineous population.

    Badii R, Bener A, Zirie M, Al-Rikabi A, Simsek M, Al-Hamaq AO, Ghoussaini M, Froguel P, Wareham NJ.

    Acta Diabetol. 2008 Mar;45(1):15-21. Epub 2007 Sep 6.PMID: 17805473 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.

    Dongxia L, Qi H, Lisong L, Jincheng G.

    Circ J. 2008 Apr;72(4):551-7.PMID: 18362424 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.

    Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Cakir N, Arslan M.

    Gynecol Endocrinol. 2006 Jun;22(6):336-42.PMID: 16785159 [PubMed - indexed for MEDLINE]Related articles

    19.

    Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study.

    Snitker S, Watanabe RM, Ani I, Xiang AH, Marroquin A, Ochoa C, Goico J, Shuldiner AR, Buchanan TA; Troglitazone in Prevention of Diabetes (TRIPOD) study.

    Diabetes Care. 2004 Jun;27(6):1365-8.PMID: 15161789 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famine.

    de Rooij SR, Painter RC, Phillips DI, Osmond C, Tanck MW, Defesche JC, Bossuyt PM, Michels RP, Bleker OP, Roseboom TJ.

    Diabetes Care. 2006 May;29(5):1052-7.PMID: 16644636 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data